Vivek Pradhan - Concepedia

Author

Vivek Pradhan

Also Known As

Dr. Vivek Pradhan, H. Noe, Pradhan, Vivek, V Pradhan, V. Pradhan, V. S. Pradhan, Vaishali Pradhan, Vijaya Pradhan, Vishal Pradhan, Vivek Pradhan

Publications

749

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Cytel (United States)University of Louisville Boston Scientific (United States)University of California San Diego

About

Vivek Pradhan is an author at Pfizer (United States) specializing in statistics, medicine, and biostatistics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	294
2	Engineering	3	3	51
3	Public Health	2	2	22
4	Allergy	1	1	11
5	Behavioral Sciences	1	1	11

Vivek Pradhan

Publications

696

Citations

H-Index

Page 1

	Year	Citations
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial Séverine Vermeire, William J. Sandborn, Silvio Danese, The Lancet InflammationAutoimmune DiseaseMucosal ImmunologyImmunologyGastroenterology	2017	197
Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study Megan N. Landis, Mark Arya, Stacy Smith, British Journal of Dermatology	2022	60
Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled study Christopher Tehlirian, Ravi Shankar Prasad Singh, Vivek Pradhan, Journal of the American Academy of Dermatology	2022	51
A comparative study of the bias corrected estimates in logistic regression Tapabrata Maiti, Vivek Pradhan Statistical Methods in Medical Research	2008	44
Choice of test for association in small sample unordered <i>r</i> × <i>c</i> tables Stian Lydersen, Vivek Pradhan, Pralay Senchaudhuri, Statistics in Medicine	2007	44
Small-sample comparisons of confidence intervals for the difference of two independent binomial proportions Thomas J. Santner, Vivek Pradhan, Pralay Senchaudhuri, Computational Statistics & Data Analysis Confidence IntervalsIndependent Binomial ProportionsBiostatisticsSmall-sample ComparisonsStatistics	2006	35
Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group study Christopher Tehlirian, Elena Peeva, Elizabeth Kieras, The Lancet Rheumatology MedicineClinical TrialsPlaque PsoriasisClinical DermatologyParallel-group Study	2020	31
Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects Indranil Bhattacharya, Sanela Tarabar, Yali Liang, Clinical Therapeutics Hormonal ContraceptiveHealthy SubjectsMedicineAnabolic SteroidsHormonal Receptor	2016	29
Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study Megan N. Landis, Stacy Smith, Gabriel Berstein, British Journal of Dermatology	2023	29
Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn’s Disease: Report of the TOSCA Study Geert D’Haens, Séverine Vermeire, Harald Vogelsang, Journal of Crohn s and Colitis	2017	28

Page 1